About EQIPD

Stakeholders

EQIPD actively involves stakeholders – from  leading research organizations but also funders and publishers – in order to collect and understand needs and expectations, current best practices and challenges.

  • Alexander Dityatev, Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
  • Alicia Faruzzi Brantley, Scripps FL
  • Andreas Scherer, European Infrastructure for Translational Medicine (EATRIS)
  • Anne-Charlotte Fauvel, European Infrastructure for Translational Medicine (EATRIS)
  • Anne-Laure Bonnefont, Institut national de la santé et de la recherche médicale (INSERM U1183)
  • Annik Leyman, Universiteit Gent
  • Arnoud Herremans, Y47
  • Ben Fitzpatrick, Tempest Technologies
  • Bernard Lerer, Hadassah – Hebrew University Medical Center
  • Bruce O’Hara, University of Kentucky (UKY)
  • Christina Dalla, National and Kapodistrian University of Athens (NKUA)
  • Claudia Pitzer University of Heidelberg (UHEI)
  • David McKinzie, Indiana University
  • Elsa Pioli, Motac Neuroscience Ltd (Motac)
  • Eric M. Prager, Wiley
  • Ernesto Prado Montes de Oca, Personalized Medicine National Laboratory (LAMPER), Medical and Pharmaceutical Biotechnology, Guadalajara Unit, CIATEJ A.C.
  • Frank Hughes, Tietronix Software
  • Frank Thadewaldt, Enso Software GmbH
  • Gerald M. Herrera, Med Associates Inc.
  • Igor Branchi, Instituto Superiore di Sanità
  • Ioannis Sotiropoulos, University of Minho
  • Irina V. Belozertseva, Pavlov Med Uni
  • Janko Samardzic, University of Belgrade
  • Jean Claude Dorego, Université de Rouen Normandie (UNIV ROUEN)
  • Jean Luc Dorego, Université de Rouen Normandie (UNIV ROUEN)
  • John Kroehle, Jr., Data Sciences International Inc.
  • Jonathan Ward, ETH Zuerich
  • Jos Prickaerts, Univeristy Maastricht
  • Judith Homberg,Radboud Universität, Nijmegen Medical Centre (RUMC)
  • Karine Cambon, Institut François Jacob/ MIRCen
  • Ken Drake, Seralogix
  • Lawrence Moon, King’s College London
  • Leonardo Restivo, Lausanne University
  • Lior Bikovski, Tel Aviv University (TAU)
  • Lucianne Groenink, Utrecht University
  • Magali Dumont, ICM-Hôpital Pitié-Salpêtrière (ICM)
  • Magali Haas, Cohen Veterans Network
  • Marianne Kordel, Deutsches Zentrum für Luft- und Raumfahrt (DLR)
  • Martin de Kort, European Infrastructure for Translational Medicine (EATRIS)
  • Michael Curtis, King’s College London (KCL)
  • Michael Schunn, Institute of Science and Technology
  • Michael Tsoory, Weizmann Institute of Science (Weizmann)
  • Natasja de Bruin & Martine Hoffmann, Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie (Frauenhofer IME)
  • Olivier Blin, Pharmacologie clinique – Hôpital de la Timone (La Timone)
  • Osvalds Pugovics, The Latvian Institute of Organic Synthesis
  • Patricia Kabitzke, Cohen Veterans Network
  • Paul Moser, CERBASCIENCE EIRL
  • Piotr Popik, Institute of Pharmacology Polish Academy of Sciences (IF-PAN)
  • Raafat Farés, Etisense SAS
  • Sabine Hölter, Helmholtz Zentrum München, Institute of Developmental Genetics (IDG)
  • Sara Wells, Medical Research Council (MRC UK)
  • Simon Loiodice, Biotrial
  • Stacey Rizzo, The Jackson Laboratory (JAX)
  • Stefanie van der Burght, Universiteit Gent
  • Sylvia Badurek, Vienna Biocenter Core Facilities GmbH (VBCF),
  • Thomas van Groen, The University of Alabama at Birmingham (UAB)
  • Todd Sherer, The Michael J. Fox Foundation
  • Valérie Bertaina-Anglade, Biotrial
  • Valerie Gailus-Durner, Helmholtz Zentrum München, Institute of Experimental Genetics (IEG)
  • Vootele Voikar, Helsinki University

If you would like to join, please contact us.